[EN] CDK2/5 DEGRADERS AND USES THEREOF<br/>[FR] AGENTS DE DÉGRADATION DE CDK2/5 ET UTILISATIONS ASSOCIÉES
申请人:DANA FARBER CANCER INST INC
公开号:WO2020206137A1
公开(公告)日:2020-10-08
The present invention relates to bifunctional compounds, compositions, and methods for treating diseases or conditions mediated by dysfunctional cyclin-dependent kinase 2 (CDK2) and CDK5 activity.
本发明涉及双重功能化合物、组合物和方法,用于治疗由功能失调的细胞周期蛋白依赖性激酶2(CDK2)和CDK5活性介导的疾病或病症。